Business Description
MustGrow Biologics Corp
NAICS : 325320
SIC : 3729
ISIN : CA62822A1030
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.9 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -1.88 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 41.5 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45.6 | |||||
3-Year EPS without NRI Growth Rate | 55.9 | |||||
3-Year FCF Growth Rate | 55.7 | |||||
3-Year Book Growth Rate | 24.1 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.24 | |||||
9-Day RSI | 25.37 | |||||
14-Day RSI | 35.8 | |||||
3-1 Month Momentum % | 86.48 | |||||
6-1 Month Momentum % | 80.6 | |||||
12-1 Month Momentum % | 33.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.38 | |||||
Quick Ratio | 4.87 | |||||
Cash Ratio | 4.46 | |||||
Days Inventory | 19983.75 | |||||
Days Payable | 38781.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.3 | |||||
Shareholder Yield % | 0.16 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 99.92 | |||||
Operating Margin % | -8.08 | |||||
Net Margin % | -4.91 | |||||
FCF Margin % | -6.22 | |||||
ROE % | -6.18 | |||||
ROA % | -4.62 | |||||
ROIC % | -48.84 | |||||
3-Year ROIIC % | 374.31 | |||||
ROC (Joel Greenblatt) % | -167.68 | |||||
ROCE % | -6.62 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | 1470 | |||||
PEG Ratio | 85.96 | |||||
PS Ratio | 14.85 | |||||
PB Ratio | 22.62 | |||||
Price-to-Tangible-Book | 22.62 | |||||
EV-to-EBIT | -264.93 | |||||
EV-to-EBITDA | -264.93 | |||||
EV-to-Revenue | 14.6 | |||||
EV-to-FCF | -206.39 | |||||
Price-to-Peter-Lynch-Fair-Value | 49 | |||||
Price-to-Graham-Number | 36.75 | |||||
Price-to-Net-Current-Asset-Value | 21.01 | |||||
Price-to-Net-Cash | 29.4 | |||||
Earnings Yield (Greenblatt) % | -0.38 | |||||
FCF Yield % | -0.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MustGrow Biologics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3.407 | ||
EPS (TTM) (€) | - | ||
Beta | 0.87 | ||
3-Year Sharpe Ratio | -0.03 | ||
3-Year Sortino Ratio | -0.07 | ||
Volatility % | 115.61 | ||
14-Day RSI | 35.8 | ||
14-Day ATR (€) | 0.049715 | ||
20-Day SMA (€) | 1.1614 | ||
12-1 Month Momentum % | 33.14 | ||
52-Week Range (€) | 0.414 - 1.53 | ||
Shares Outstanding (Mil) | 51.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MustGrow Biologics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MustGrow Biologics Corp Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
MustGrow Biologics Corp Frequently Asked Questions
What is MustGrow Biologics Corp(FRA:0C0)'s stock price today?
When is next earnings date of MustGrow Biologics Corp(FRA:0C0)?
Does MustGrow Biologics Corp(FRA:0C0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |